Allanore Y, Simms R, Distler O, Trojanowska M, Pope J, Denton CP, et al. Systemic sclerosis. Nat Rev Dis Primers. 2015;1:15002.
Bairkdar M, Rossides M, Westerlind H, Hesselstrand R, Arkema EV, Holmqvist M. Incidence and prevalence of systemic sclerosis globally: a comprehensive systematic review and meta-analysis. Rheumatology. 2021;60(7):3121–33.
Jaeger VK, Wirz EG, Allanore Y, Rossbach P, Riemekasten G, Hachulla E, et al. Incidences and risk factors of organ manifestations in the early course of systemic sclerosis: a longitudinal EUSTAR study. PLoS ONE. 2016;11(10):e0163894.
Kowal-Bielecka O, Fransen J, Avouac J, Becker M, Kulak A, Allanore Y, et al. Update of EULAR recommendations for the treatment of systemic sclerosis. Ann Rheum Dis. 2017;76(8):1327–39.
Walker UA, Saketkoo LA, Distler O. Haematopoietic stem cell transplantation in systemic sclerosis. RMD Open. 2018;4(1):e000533.
Kwakkenbos L, Delisle VC, Fox RS, Gholizadeh S, Jewett LR, Levis B, et al. Psychosocial aspects of scleroderma. Rheum Dis Clin N Am. 2015;41(3):519–28.
Bassel M, Hudson M, Taillefer SS, Schieir O, Baron M, Thombs BD. Frequency and impact of symptoms experienced by patients with systemic sclerosis: results from a Canadian National Survey. Rheumatology (Oxford). 2011;50(4):762–7.
Hudson M, Thombs BD, Steele R, Watterson R, Taillefer S, Baron M, et al. Clinical correlates of quality of life in systemic sclerosis measured with the World Health Organization Disability Assessment Schedule II. Arthritis Rheum. 2008;59(2):279–84.
Decuman S, Smith V, Verhaeghe S, Deschepper E, Vermeiren F, De Keyser F. Work participation and work transition in patients with systemic sclerosis: a cross-sectional study. Rheumatology (Oxford). 2012;51(2):297–304.
Sierakowska M, Doroszkiewicz H, Sierakowska J, Olesinska M, Grabowska-Jodkowska A, Brzosko M, et al. Factors associated with quality of life in systemic sclerosis: a cross-sectional study. Qual Life Res. 2019;28(12):3347–54.
Frantz C, Avouac J, Distler O, Amrouche F, Godard D, Kennedy AT, et al. Impaired quality of life in systemic sclerosis and patient perception of the disease: a large international survey. Semin Arthritis Rheum. 2016;46(1):115–23.
van Leeuwen NM, Ciaffi J, Liem SIE, Huizinga TWJ, de Vries-Bouwstra JK. Health-related quality of life in patients with systemic sclerosis: evolution over time and main determinants. Rheumatology (Oxford). 2021;60(8):3646–55.
Park EH, Strand V, Oh YJ, Song YW, Lee EB. Health-related quality of life in systemic sclerosis compared with other rheumatic diseases: a cross-sectional study. Arthritis Res Ther. 2019;21(1):61.
Willems LM, Kwakkenbos L, Bode C, van den Hoogen FH, van den Ende CH. Health care use and patients’ perceptions on quality of care in systemic sclerosis. Clin Exp Rheumatol. 2013;31(2 Suppl 76):64–70.
Spierings J, van den Ende C, Schriemer R, de Pundert L, Moens HB, van Laar J, et al. Optimal care for systemic sclerosis patients: recommendations from a patient-centered and multidisciplinary mixed-method study and working conference. Clin Rheumatol. 2019;38(4):1007–15.
Spierings J, van Rhijn-Brouwer FCC, de Bresser CJM, Mosterman PTM, Pieterse AH, Vonk MC, et al. Treatment decision-making in diffuse cutaneous systemic sclerosis: a patient’s perspective. Rheumatology (Oxford). 2020;59(8):2052–61.
Stocker JK, Vonk MC, van den Hoogen FHJ, Nijhuis-van der Sanden MWG, Spierings J, Staal JB, et al. Room for improvement in non-pharmacological systemic sclerosis care? A cross-sectional online survey of 650 patients. BMC Rheumatol. 2020;4:43.
Bodenheimer T, Lorig K, Holman H, Grumbach K. Patient self-management of chronic disease in primary care. JAMA. 2002;288(19):2469–75.
Gee PM, Greenwood DA, Paterniti DA, Ward D, Miller LM. The eHealth Enhanced Chronic Care Model: a theory derivation approach. J Med Internet Res. 2015;17(4):e86.
Wagner EH. Chronic disease management: what will it take to improve care for chronic illness? Eff Clin Pract. 1998;1(1):2–4.
Davy C, Bleasel J, Liu H, Tchan M, Ponniah S, Brown A. Effectiveness of chronic care models: opportunities for improving healthcare practice and health outcomes: a systematic review. BMC Health Serv Res. 2015;15:194.
Brand CA, Ackerman IN, Tropea J. Chronic disease management: improving care for people with osteoarthritis. Best Pract Res Clin Rheumatol. 2014;28(1):119–42.
Coleman K, Austin BT, Brach C, Wagner EH. Evidence on the chronic care model in the new millennium. Health Aff (Millwood). 2009;28(1):75–85.
Stellefson M, Dipnarine K, Stopka C. The chronic care model and diabetes management in US primary care settings: a systematic review. Prev Chronic Dis. 2013;10:E26.
Glasgow RE, Wagner EH, Schaefer J, Mahoney LD, Reid RJ, Greene SM. Development and validation of the Patient Assessment of Chronic Illness Care (PACIC). Med Care. 2005;43(5):436–44.
Desmedt M, Vertriest S, Petrovic M, Bergs J, Vrijhoef H, Dessers E, et al. Seen through the patients’ eyes: quality of chronic illness care. Fam Pract. 2018;35(4):446–51.
Schmittdiel J, Mosen DM, Glasgow RE, Hibbard J, Remmers C, Bellows J. Patient Assessment of Chronic Illness Care (PACIC) and improved patient-centered outcomes for chronic conditions. J Gen Intern Med. 2008;23(1):77–80.
Malliarou M, Desikou C, Lahana E, Kotrotsiou S, Paralikas T, Nikolentzos A, et al. Diabetic patient assessment of chronic illness care using PACIC. BMC Health Serv Res. 2020;20(1):543.
Glasgow RE, Whitesides H, Nelson CC, King DK. Use of the Patient Assessment of Chronic Illness Care (PACIC) with diabetic patients: relationship to patient characteristics, receipt of care, and self-management. Diabetes Care. 2005;28(11):2655–61.
Bo A, Jensen NH, Bro F, Nicolaisen SK, Maindal HT. Higher patient assessed quality of chronic care is associated with lower diabetes distress among adults with early-onset type 2 diabetes: cross-sectional survey results from the Danish DD2-study. Prim Care Diabetes. 2020;14(5):522–8.
Iglesias K, De Geest S, Berben L, Dobbels F, Denhaerynk K, Russell LC, et al. Validation of the patient assessment of chronic illness care (PACIC) short form scale in heart transplant recipients: the international cross-sectional bright study. BMC Health Serv Res. 2020;20(1):160.
Burton J, Murphy E, Riley P. Primary immunodeficiency disease: a model for case management of chronic diseases. Prof Case Manag. 2010;15(1):5–10 (2-4; quiz 5-6).
Pericleous M, Kelly C, Ala A, De Lusignan S. The role of the chronic care model in promoting the management of the patient with rare liver disease. Expert Rev Gastroenterol Hepatol. 2018;12(8):829–41.
Pai M, Key NS, Skinner M, Curtis R, Feinstein M, Kessler C, et al. NHF-McMaster guideline on care models for haemophilia management. Haemophilia. 2016;22(Suppl 3):6–16.
Stuber KJ, Langweiler M, Mior S, McCarthy PW. A pilot study assessing patient-centred care in patients with chronic health conditions attending chiropractic practice. Complement Ther Med. 2018;39:1–7.
Arditi C, Iglesias K, Peytremann-Bridevaux I. The use of the Patient Assessment of Chronic Illness Care (PACIC) instrument in diabetes care: a systematic review and meta-analysis. Int J Qual Health Care. 2018;30(10):743–50.
Rick J, Rowe K, Hann M, Sibbald B, Reeves D, Roland M, et al. Psychometric properties of the Patient Assessment Of Chronic Illness Care measure: acceptability, reliability and validity in United Kingdom patients with long-term conditions. BMC Health Serv Res. 2012;12:293.
Kocher A, Simon M, Dwyer AA, Villiger PM, Kunzler-Heule P, De Geest S, et al. Developing a rare disease chronic care model: management of systemic sclerosis (MANOSS) study protocol. J Adv Nurs. 2019;75(12):3774–91.
Creswell JW, Plano Clark VL. Designing and conducting mixed methods research, 2nd. edition. Thousand Oaks: Sage Publications; 2011.
Gugiu C, Coryn CL, Applegate B. Structure and measurement properties of the Patient Assessment of Chronic Illness Care instrument. J Eval Clin Pract. 2010;16(3):509–16.
Iglesias K, Burnand B, Peytremann-Bridevaux I. PACIC Instrument: disentangling dimensions using published validation models. Int J Qual Health Care. 2014;26(3):250–60.
Sijtsma K, van der Ark LA. A tutorial on how to do a Mokken scale analysis on your test and questionnaire data. Br J Math Stat Psychol. 2017;70(1):137–58.
Ndosi M, Alcacer-Pitarch B, Allanore Y, Del Galdo F, Frerix M, Garcia-Diaz S, et al. Common measure of quality of life for people with systemic sclerosis across seven European countries: a cross-sectional study. Ann Rheum Dis. 2018;77(7):1032–8.
Kocher A, Ndosi M, Denhaerynck K, Simon M, Dwyer AA, Distler O, et al. A rare disease patient-reported outcome measure: revision and validation of the German version of the Systemic Sclerosis Quality of Life Questionnaire (SScQoL) using the Rasch model. Orphanet J Rare Dis. 2021;16(1):356.
Kocher A, Ndosi M, Hoeper K, Simon M, Nicca D. Revision and validation of the German version of the systemic sclerosis quality of life questionnaire (Sscqol) with Mokken scale analysis. Ann Rheumatic Dis. 2020;79:550–1.
Sangha O, Stucki G, Liang MH, Fossel AH, Katz JN. The self-administered comorbidity questionnaire: a new method to assess comorbidity for clinical and health services research. Arthritis Rheum. 2003;49(2):156–63.
Hudson M, Bernatsky S, Taillefer S, Fortin PR, Wither J, Baron M, et al. Patients with systemic autoimmune diseases could not distinguish comorbidities from their index disease. J Clin Epidemiol. 2008;61(7):654–62.
Spagnolo P, Cordier JF, Cottin V. Connective tissue diseases, multimorbidity and the ageing lung. Eur Respir J. 2016;47(5):1535–58.
Signorell A. DescTools: tools for descriptive statistics. R package version 0.99.41. https://cran.r-project.org/package=DescTools. Accessed 14 May 2021.
Yoshida K, Bartel A. tableone: create 'Table 1' to describe baseline characteristics with or without propensity score weights. R package version 0.12.0. https://CRAN.R-project.org/package=tableone. Accessed 14 May 2021.
Faraone SV. Interpreting estimates of treatment effects: implications for managed care. Pharm Ther. 2008;33(12):700–11.
Wei T, Simko V. R package 'corrplot': visualization of a correlation matrix (Version 0.90)2021. https://cran.r-project.org/web/packages/corrplot/corrplot.pdf.
Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3(2):77–101.
Braun V, Clarke V, Hayfield N, Terry G. Thematic analysis. In: Liamputtong P, editor. Handbook of research methods in health social sciences. Singapore: Springer; 2019. p. 843–60.
EURORDIS. Improve our experience of health care! Key findings from a survey on patients' and carers' experience of medical care for their rare diseases 2021. https://download2.eurordis.org/rbv/HCARE/HCARE_FS_long.pdf.
Boland MR, Kruis AL, Huygens SA, Tsiachristas A, Assendelft WJ, Gussekloo J, et al. Exploring the variation in implementation of a COPD disease management programme and its impact on health outcomes: a post hoc analysis of the RECODE cluster randomised trial. NPJ Prim Care Respir Med. 2015;25:15071.
Staniszewska SH, Henderson L. Patients’ evaluations of the quality of care: influencing factors and the importance of engagement. J Adv Nurs. 2005;49(5):530–7.
Kocher A, Adler S, Spichiger E. Skin and mucosa care in systemic sclerosis–patients’ and family caregivers’ experiences and expectations of a specific education programme: a qualitative study. Musculoskelet Care. 2013;11(3):168–78.
Mouthon L, Alami S, Boisard AS, Chaigne B, Hachulla E, Poiraudeau S. Patients’ views and needs about systemic sclerosis and its management: a qualitative interview study. BMC Musculoskelet Disord. 2017;18(1):230.
Nakayama A, Tunnicliffe DJ, Thakkar V, Singh-Grewal D, O’Neill S, Craig JC, et al. Patients’ perspectives and experiences living with systemic sclerosis: a systematic review and thematic synthesis of qualitative studies. J Rheumatol. 2016;43(7):1363–75.
Robson JC, Shepherd M, Harper L, Ndosi M, Austin K, Flurey C, et al. Psychological and self-management support for people with vasculitis or connective tissue diseases: UK health professionals’ perspectives. Rheumatol Adv Pract. 2020;4(2):rkaa016.
Kwakkenbos L, Carboni-Jimenez A, Carrier ME, Pepin M, Pelaez S, Malcarne VL, et al. Reasons for not participating in scleroderma patient support groups: a comparison of results from the North American and European scleroderma support group surveys. Disabil Rehabil. 2019;43:1279–86.
Joseph-Williams N, Lloyd A, Edwards A, Stobbart L, Tomson D, Macphail S, et al. Implementing shared decision making in the NHS: lessons from the MAGIC programme. BMJ. 2017;357:j1744.
Muscat DM, Morony S, Trevena L, Hayen A, Shepherd HL, Smith SK, et al. Skills for shared decision-making: evaluation of a health literacy program for consumers with lower literacy levels. Health Lit Res Pract. 2019;3(3 Suppl):S58–74.
De Pietro C, Camenzind P, Sturny I, Crivelli L, Edwards-Garavoglia S, Spranger A, et al. Switzerland: health system review. Health Syst Transit. 2015;17(4):1–288.
Schouffoer AA, Zirkzee EJ, Henquet SM, Caljouw MA, Steup-Beekman GM, van Laar JM, et al. Needs and preferences regarding health care delivery as perceived by patients with systemic sclerosis. Clin Rheumatol. 2011;30(6):815–24.
Spierings J, van den Ende CHM, Schriemer RM, Bernelot Moens HJ, van der Bijl EA, Bonte-Mineur F, et al. How do patients with systemic sclerosis experience currently provided healthcare and how should we measure its quality? Rheumatology (Oxford). 2020;59(6):1226–32.
Stocker JK, Vonk MC, van den Hoogen FHJ, Nijhuis-van der Sanden MWG, Spierings J, Staal JB, et al. Opening the black box of non-pharmacological care in systemic sclerosis: a cross-sectional online survey of Dutch health professionals. Rheumatol Int. 2020;41:1299–310.
Spijk-de Jonge MJ, Weijers JM, Teerenstra S, Elwyn G, van de Laar MA, van Riel PL, et al. Patient involvement in rheumatoid arthritis care to improve disease activity-based management in daily practice: a randomized controlled trial. Patient Educ Couns. 2021;105:1244–53.
Doyle M. Peer support and mentorship in a us rare disease community: findings from the cystinosis in emerging adulthood study. Patient. 2015;8(1):65–73.
Badiu C, Bonomi M, Borshchevsky I, Cools M, Craen M, et al. Developing and evaluating rare disease educational materials co-created by expert clinicians and patients: the paradigm of congenital hypogonadotropic hypogonadism. Orphanet J Rare Dis. 2017;12(1):57.
Frei A, Senn O, Chmiel C, Reissner J, Held U, Rosemann T. Implementation of the chronic care model in small medical practices improves cardiovascular risk but not glycemic control. Diabetes Care. 2014;37(4):1039–47.
Scherz N, Bachmann-Mettler I, Chmiel C, Senn O, Boss N, Bardheci K, et al. Case management to increase quality of life after cancer treatment: a randomized controlled trial. BMC Cancer. 2017;17(1):1–8.
Chmiel C, Giewer I, Frei A, Rosemann T. Four-year long-term follow-up of diabetes patients after implementation of the Chronic Care Model in primary care: a cross-sectional study. Swiss Med Wkly. 2017. https://doi.org/10.4414/smw.2017.14522.
White S, Foster R, Marks J, Morshead R, Goldsmith L, Barlow S, et al. The effectiveness of one-to-one peer support in mental health services: a systematic review and meta-analysis. BMC Psychiatry. 2020. https://doi.org/10.1186/s12888-020-02923-3.
Granstrom E, Wannheden C, Brommels M, Hvitfeldt H, Nystrom ME. Digital tools as promoters for person-centered care practices in chronic care? Healthcare professionals’ experiences from rheumatology care. BMC Health Serv Res. 2020;20(1):1108.
Speerin R, Slater H, Li L, Moore K, Chan M, Dreinhofer K, et al. Moving from evidence to practice: Models of care for the prevention and management of musculoskeletal conditions. Best Pract Res Clin Rheumatol. 2014;28(3):479–515.
Dwyer AA, Quinton R, Morin D, Pitteloud N. Identifying the unmet health needs of patients with congenital hypogonadotropic hypogonadism using a web-based needs assessment: implications for online interventions and peer-to-peer support. Orphanet J Rare Dis. 2014;9:83.
Spicer J, Budge C, Carryer J. Taking the PACIC back to basics: the structure of the Patient Assessment of Chronic Illness Care. J Eval Clin Pract. 2012;18(2):307–12.
Muncer SJ, Speak B. Mokken scale analysis and confirmatory factor analysis of the Health of the Nation Outcome Scales. Personal Individ Differ. 2016;94:272–6.